Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

71.12 USD +1.03 (+1.47%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 6, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,464,402
Open 70.28
Bid (Size) 71.20 (6)
Ask (Size) 71.71 (3)
Prev. Close 70.09
Today's Range 67.15 - 71.18
52wk Range 67.15 - 220.20
Shares Outstanding 76,526,964
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Implied ESML Analyst Target Price: $49
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Jim Cramer Shares His Thoughts On Chegg, Bristol-Myers Squibb And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said with Matterport, Inc. (NASDAQ: MTTR) already moving too much, ... 
Tags LMND CRSP Trading Ideas
From Benzinga

Performance

YTD
-54.99%
-54.99%
1 Month
-21.19%
-21.19%
3 Month
-40.98%
-40.98%
6 Month
-40.34%
-40.34%
1 Year
-52.50%
-52.50%

More News

Read More
Why CRISPR Therapeutics Stock Sank 12.5% in November
Tags Market News CRSP Recent Press Releases
From Motley Fool
Is Vertex Pharmaceuticals Stock a Buy Now?
Tags CRSP Recent Press Releases VRTX
From Motley Fool
3 Stocks Cathie Wood Is Selling That Are Still Great Picks to Buy and Hold
Tags VRTX Market News CRSP
From Motley Fool
First Week of July 2022 Options Trading For CRISPR Therapeutics
Tags Stocks
From Market News Video
Will This Beaten-Down Stock Bounce Back? 3 Things to Know
Tags Recent Press Releases CRSP Market News
From Motley Fool
Biotech Stocks are Due for a Rally
Tags Pharma/Biotech Healthcare Market News
From TalkMarkets
Do CRISPR Therapeutics and Intellia Face a Big Safety Risk?
Tags Market News NTLA CRSP
From Motley Fool
Being First Is Not Enough For Crispr Therapeutics
Tags CRSP BEAM Hot Stocks
From InvestorPlace
Better Buy: Vertex Pharmaceuticals vs. CRISPR
Tags CRSP Recent Press Releases BLUE
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.